Glioma - adjuvant treatment and follow-up
Association of age with the molecular profile and outcome in patients with IDH-wildtype glioblastoma
Soluble circulating immune checkpoint molecules in malignant brain tumors
Monitoring of the tumor status in glioblastoma patients via Porphyrin biosynthesis – a promising approach
Regorafenib-A feasible option as third-line therapy of recurrent glioblastoma?
The Alcatraz-Strategy: a novel multimodal therapeutic approach for glioblastoma
FGFR3-TACC3-fusion in glioblastoma is associated with younger age and longer overall survival